Stockwinners Market Radar for November 04, 2017 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
S... | Hot Stocks14:39 EDT T-Mobile, Sprint jointly announce end of merger talks - T-Mobile (TMUS) and Sprint (S) jointly announced that they have ceased talks to merge as the companies were unable to find mutually agreeable terms. "The prospect of combining with Sprint has been compelling for a variety of reasons, including the potential to create significant benefits for consumers and value for shareholders. However, we have been clear all along that a deal with anyone will have to result in superior long-term value for T-Mobile's shareholders compared to our outstanding stand-alone performance and track record," said John Legere, President and CEO of T-Mobile US. "Going forward, T-Mobile will continue disrupting this industry and bringing our proven Un-carrier strategy to more customers and new categories - ultimately redefining the mobile Internet as we know it. We've been out-growing this industry for the last 15 quarters, delivering outstanding value for shareholders, and driving significant change across wireless. We won't stop now." Sprint President and CEO and Softbank (SFTBY) board member Marcelo Claure said: "While we couldn't reach an agreement to combine our companies, we certainly recognize the benefits of scale through a potential combination. However, we have agreed that it is best to move forward on our own. We know we have significant assets, including our rich spectrum holdings, and are accelerating significant investments in our network to ensure our continued growth. As convergence in the connectivity marketplace continues, we believe significant opportunities exist to establish strong partnerships across multiple industries. We are determined to continue our efforts to change the wireless industry and compete fiercely. We look forward to continuing to take the fight to the duopoly and newly emerging competitors."
|
HZNP | Hot Stocks12:18 EDT Horizon Pharma presents results from PROCYSBI open-label study in children - Horizon Pharma has announced results from a new open-label study evaluating the effects of PROCYSBI delayed-release capsules in treatment-naive children younger than 6 years of age living with nephropathic cystinosis. The data was presented at the American Society of Nephrology Kidney Week 2017 Annual Meeting in New Orleans. In the United States, PROCYSBI is a cystine depleting agent indicated for the treatment of nephropathic cystinosis in adults and pediatric patients two years of age and older. In the study, children enrolled achieved lowered and prolonged maintenance of white blood cell cystine levels - the biomarker for disease control - over the course of one year of therapy. Additionally, they experienced measured improvements in height, weight and body surface area.
|
KERX | Hot Stocks12:15 EDT Keryx announces presentation of real world dialysis data of Auryxia - Keryx Biopharmaceuticals has presented new real world data from a large dialysis provider that showed Auryxia tablets, when dosed as a phosphate binder, reduced erythropoiesis-stimulating agent and intravenous iron use, while maintaining hemoglobin levels in patients on dialysis. The data was presented in a poster at the American Society of Nephrology's 2017 Kidney Week taking place in New Orleans. Auryxia is FDA-approved as a phosphate binder indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis. Keryx is seeking to expand the indication for Auryxia to include the treatment of iron deficiency anemia in patients with non-dialysis dependent chronic kidney disease. A supplemental new drug application is under review by the FDA, with a Prescription Drug User Fee Act target action date of November 6, 2017.
|
GS... | Hot Stocks09:48 EDT Week in review: How Trump's policies moved stocks - Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap compiled by The Fly: 1. TAX REFORM: On Thursday, House Republicans released the long-awaited tax bill that seeks to simplify the tax code and reduce corporate rates. The "Tax Cuts and Jobs Act" wants to reduce the number of tax brackets from seven to four, maintaining the top marginal rate at 39.6%, and almost double the standard deduction, according to ABC News. The bill also would permanently reduce the U.S. corporate tax rate from 35% to 20%, the report noted. 2. HOMEBUILDERS: Several names in the homebuilding space were under pressure on Thursday after the Republican tax plan proposed capping the mortgage interest tax deduction to new mortgages of $500,000 or less. Presently, Americans can deduct interest on mortgages of up to $1M from their income. Publicly traded homebuilders include Beazer Homes (BZH), D.R. Horton (DHI), Hovnanian (HOV), KB Home (KBH), Lennar (LEN), M.D.C. Holdings (MDC), CalAtlantic (CAA), PulteGroup (PHM) and Toll Brothers (TOL). 3. RENEWABLE ENERGY: B. Riley FBR analyst Benjamin Salisbury called the House tax reform proposal a "mixed bag" for renewable energy credits, noting that it would end the tax credit for commercial-scale solar projects after 2027, reduce the available wind tax credit and extend the orphaned tax credits, including fuel cells. The plan is still being negotiated and Salisbury sees a 30%-40% probability that Congress can pass a tax cut mirroring the recent GOP blueprint and a 55%-65% chance they could pass a scaled-down version. Publicly traded companies in the solar space include Canadian Solar (CSIQ), First Solar (FSLR), JA Solar (JASO), SunPower (SPWR), Trina Solar (TSL) and Yingli Green Energy (YGE). 4. PLUG POWER: Following the Republican tax bill announcement, Plug Power (PLUG) said in a blog post that, "Included in the bill is a provision that would reinstate the Fuel Cell Investment Tax Credit. We applaud the Committee for addressing the market disparity that was created in 2015. [...] As we await passage in the House and then turn to the Senate, we are confident that our champions in both houses will keep fighting to get this done and restore parity for our growing industry here in the United States helping protect and grow good paying American manufacturing and service jobs." 5. GOLDMAN SACHS: According to a report by Reuters earlier this week, Goldman Sachs (GS) CEO Lloyd Blankfein is planning to visit China as part of a business delegation at the same time as President Trump intends to visit the country. Blankfein will be the only executive of a major financial institution traveling to China as part of the trade mission, which is being led by U.S. Commerce Secretary Wilbur Ross, the report noted. Executives from companies such as GE (GE), Honeywell (HON), and Boeing (BA) are on the list, in addition to a large number of leaders from energy and commodities groups, the publication added. 6. RUSSIA INVESTIGATION: Earlier this week, Bloomberg said that former Trump adviser George Papadopoulos claims that top campaign officials for Donald Trump agreed to a pre-election meeting with representatives of Russian President Vladimir Putin. There is no indication that any such meeting ever actually happened, the report noted. Meanwhile, Google (GOOG, GOOGL), Facebook (FB) and other tech firms met earlier this month to discuss potential joint strategies to address congressional concerns at hearings regarding Russian influence on the 2016 election amid a populist turn against the companies, according to The Wall Street Journal. "Week in Review" is The Fly's weekly recap of its recurring series of "Trump Effect" exclusive stories.
|